Archana Chatterjee

Comparison of the immunogenicity and safety of<i>Cervarix</i>™ and<i>Gardasil</i>^®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

Mark H. Einstein, Mira Baron, Myron J. Levin et al. · Human Vaccines · 2009 · 396 citations · Full text

Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics

Charles R. Woods, John S. Bradley, Archana Chatterjee et al. · Journal of the Pediatric Infectious Diseases Society · 2021 · 242 citations

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Cosette M. Wheeler, S. Rachel Skinner, Maria Rowena Del Rosario‐Raymundo et al. · The Lancet Infectious Diseases · 2016 · 187 citations

Vaccination, Vaccine Safety, Vaccinology +12

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

S. Rachel Skinner, Anne Szarewski, Barbara Romanowski et al. · The Lancet · 2014 · 180 citations

Vaccination, Vaccine Safety, Vaccinology +13

Striving for Gender Equity in Academic Medicine Careers: A Call to Action

Carol K. Bates, Lynn K. Gordon, Elizabeth L. Travis et al. · Academic Medicine · 2016 · 177 citations · Full text

Women Empowerment, Nursing, Academic Medicine Careers +13